| 注册
首页|期刊导航|中国医药科学|经皮冠状动脉介入治疗术后新发焦虑抑郁机制的研究进展

经皮冠状动脉介入治疗术后新发焦虑抑郁机制的研究进展

陈利浩 李思琦 姜佳慧 杨旭娜 顾文博 陈泽宇 南寒

中国医药科学2025,Vol.15Issue(2):28-31,4.
中国医药科学2025,Vol.15Issue(2):28-31,4.DOI:10.20116/j.issn2095-0616.2025.02.07

经皮冠状动脉介入治疗术后新发焦虑抑郁机制的研究进展

Research progress on the mechanism of new anxiety and depression after percutaneous coronary intervention

陈利浩 1李思琦 2姜佳慧 1杨旭娜 1顾文博 1陈泽宇 1南寒1

作者信息

  • 1. 辽宁中医药大学第一临床学院,辽宁 沈阳 110000
  • 2. 辽宁中医药大学附属医院心内二科,辽宁 沈阳 110000
  • 折叠

摘要

Abstract

Percutaneous coronary intervention(PCI)has become a widely used strategy for the treatment of cardiovascular disease.As an invasive treatment,patients are susceptible to anxiety and depression in the postoperative period,which seriously affects their prognosis.In recent years,with the development of research on double heart disease,physicians have become more concerned about emphasizing the impact of psychological factors on heart disease.Western medicine believes that anxiety and depression after PCI is mainly related to inflammatory response,platelet aggregation,neuroendocrine mechanism and D-type personality theory,and based on this,patients are given pharmacological and non-pharmacological treatments.This article mainly reviews the pathogenesis of anxiety and depression after PCI.

关键词

经皮冠状动脉介入治疗/焦虑/抑郁/发病机制/中西医治疗

Key words

Percutaneous coronary intervention/Anxiety/Depression/Pathogenesis/Traditional Chinese and Western medicine treatment

分类

医药卫生

引用本文复制引用

陈利浩,李思琦,姜佳慧,杨旭娜,顾文博,陈泽宇,南寒..经皮冠状动脉介入治疗术后新发焦虑抑郁机制的研究进展[J].中国医药科学,2025,15(2):28-31,4.

基金项目

辽宁省沈阳市科学技术计划-公共卫生研发专项(联合项目)(21-174-9-04). (联合项目)

中国医药科学

2095-0616

访问量0
|
下载量0
段落导航相关论文